Dr. Reddy’s unveils new formulation of Naloxone Injection | All the latest regulatory news on the portal Medznat.ru. :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Dr. Reddy’s unveils new formulation of Naloxone Injection

Dr. Reddy’s unveils new formulation of Naloxone Injection Dr. Reddy’s unveils new formulation of Naloxone Injection
Dr. Reddy’s unveils new formulation of Naloxone Injection Dr. Reddy’s unveils new formulation of Naloxone Injection

What's new?

IV administration of single-dose prefilled syringe of Naloxone Injection can be recommended in emergency situations of narcotic overdose.

Dr. Reddy’s Laboratories asserted the availability of Naloxone Hydrochloride Injection which will be available as 2mg/2mL single-dose prefilled syringes.

Naloxone hydrochloride belongs to opioid antagonist drug class. It is used for the treatment of opioid depression, and for analysis of alleged or known acute opioid overdose. It may be administered as intravenous (IV), intramuscular (IM), or subcutaneous (SC). 

The fastest onset of action is attained by IV administration, which is suggested in emergency conditions associated with narcotic overdose. The patients should be carefully and continuously observed as the duration of action of some opioids may surpass that of naloxone. When needed, the frequent doses of naloxone should be given.

Article:

Dr. Reddy’s Launches Naloxone HCl Injection in Single-Dose Prefilled Syringes

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies ru en
Try: